埃瓦尔快速跟踪,实施一个安全和经济有效的协议
Rita Calviño López-Villalta1, Nilo Javier Mosquera Arochena1
1Hospital Clínico Santiago de Compostela, A Coruña, Spain, Vascular Surgery Department.
Portuguese journal of cardiac thoracic and vascular surgery
|February 20, 2026
概括
实施选择性内血管动脉瘤修复 (EVAR) 的快速方案可显著降低住院时间和费用. 这种方法是安全的,不增加不良事件或再入院,使其成为潜在的护理标准.
科学领域:
- 血管外科 血管外科
- 卫生经济学 卫生经济学
- 患者管理 患者管理
背景情况:
- 选择性内血管动脉瘤修复 (EVAR) 是一种常见的程序.
- 优化患者出院协议对于效率和成本效益至关重要.
- 评估快速通道协议可以确定外科手术期间护理的改善.
研究的目的:
- 评估接受选择性EVAR的患者快速出院协议的成本效益和安全性.
- 为了比较根据快速通道协议管理的患者与标准入院之间的结果.
主要方法:
- 对接受选择性EVAR的83名患者进行了回顾性分析.
- 快速治疗组 (40名患者) 与标准入院的对照组 (43名患者) 的比较.
- 数据收集包括停留时间,费用,再干预率,不良事件和30天和6个月的再接收.
主要成果:
- 快速治疗组的住院时间显著缩短 (2.3天而不是3.7天),以及对复苏室监测的需求减少.
- 快速治疗组中观察到的二次干预率 (12.5%对23.3%) 和再录取率较低.
- 每位患者的总成本节省是相当大的,在快速治疗组中平均为1936.05欧元 (1403.29欧元与3339.34欧元).
结论:
- 选择性EVAR的快速通道协议有效地缩短了住院时间,并降低了外科手术期间的成本.
- 该协议不会增加不良事件或再接收率.
- 快速实施EVAR应被视为符合条件的患者的标准做法.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
38
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
38
Modified-Release Drug Delivery Systems: Rate-Programmed I
28
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
28
Clinically Relevant Drug Product Specifications: Methods of Establishment
246
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
246
Effects of EDTA on End-Point Detection Methods
691
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
691


